Alpha-fetoprotein with AFP-L3%-994

Test info

  
Alpha-fetoprotein with AFP-L3%
  
994
  
LAB994
  
MSO
  
α-Fetoprotein
AFP
  

The AFP-L3% assay is intended for use in the assessment of risk for the development of hepatocellular carcinoma (HCC) in patients with chronic liver diseases.

Values obtained with different assay methods should not be used interchangeably in serial testing. It is recommended that only one assay method be used consistently to monitor each patient's course of therapy.

Specimen

  
Serum
  
  
0.5 mL
  
0.3 mL
Note: this volume does not allow for repeat testing
  

Spin

  

Gold serum separator (SST) tube

  
  
0.5 mL
  

Spin and separate

  
  

Refrigerated (preferred) - 9 days

Frozen - 9 days

Ambient - 9 days

  
  • Gross icterus

Performance

  
LabCorp Burlington (141300): R-NX
  
Mo - Fr
  
1 - 3 days
  

Liquid-phase Binding assay

Clinical and Interpretive info

  

AFP Serum: 0.0 - 8.0 ng/dL
AFP L3%:    0.0 - 9.9 %

Billing

  
82107
  
Result 42332-7

Tracking

  
06/03/2019
  
10/26/2020